000 01380 a2200349 4500
005 20250516130530.0
264 0 _c20140213
008 201402s 0 0 eng d
022 _a1875-5992
024 7 _a10.2174/18715206113139990130
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSun, Hui
245 0 0 _aNatural products targeting autophagy via the PI3K/Akt/mTOR pathway as anticancer agents.
_h[electronic resource]
260 _bAnti-cancer agents in medicinal chemistry
_cSep 2013
300 _a1048-56 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aAutophagy
_xdrug effects
650 0 4 _aBiological Products
_xpharmacology
650 0 4 _aHumans
650 0 4 _aMolecular Targeted Therapy
_xmethods
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aPhosphatidylinositol 3-Kinase
_xmetabolism
650 0 4 _aProto-Oncogene Proteins c-akt
_xmetabolism
650 0 4 _aSignal Transduction
_xdrug effects
650 0 4 _aTOR Serine-Threonine Kinases
_xmetabolism
700 1 _aWang, Zhaoye
700 1 _aYakisich, Juan Sebastian
773 0 _tAnti-cancer agents in medicinal chemistry
_gvol. 13
_gno. 7
_gp. 1048-56
856 4 0 _uhttps://doi.org/10.2174/18715206113139990130
_zAvailable from publisher's website
999 _c22397319
_d22397319